Table 3.

Relative odds of PAD according to VAI in different models among normal-weight hypertensive patients in different sex

VAI Index	Participants, n	Cases, n	PAD, OR (95%CI)
			Model 1	Model 2	Model 3	Model4
Male
Per 1 unit increase	3195	127 (3.97%)	1.65 (1.26, 2.17)	1.94 (1.46, 2.59)	1.96 (1.38, 2.79)	2.12 (1.46, 3.07)
Quartiles
Q1 (< 0.64)	799	18 (2.25%)	Reference	Reference	Reference	Reference
Q2 (1.17 to < 1.76)	798	37 (4.64%)	1.98 (1.11, 3.54)	2.20 (1.22, 3.94)	1.89 (0.95, 3.76)	1.94 (0.97, 3.90)
Q3 (1.76 to < 2.74)	799	37 (4.63%)	2.18 (1.22, 3.89)	2.56 (1.41, 4.62)	2.32 (1.16, 4.63)	2.27 (1.13, 4.60)
Q4 (≥ 2.74)	799	35 (4.38%)	2.83 (1.57, 5.09)	3.67 (1.99, 6.77)	3.11 (1.49, 6.49)	3.26 (1.53, 6.93)
Female
Per 1 unit increase	3420	85 (2.49%)	1.34 (0.96, 1.86)	1.44 (1.03, 2.03)	1.24 (0.83, 1.86)	1.28 (0.85, 1.95)
Quartiles
Q1 (< 1.17)	855	14 (1.64%)	Reference	Reference	Reference	Reference
Q2 (1.17 to < 1.76)	855	23 (2.69%)	1.62 (0.82, 3.20)	1.70 (0.86, 3.36)	1.20 (0.54, 2.68)	1.23 (0.54, 2.75)
Q3 (1.76 to < 2.74)	855	23 (2.69%)	1.80 (0.91, 3.54)	1.85 (0.93, 3.66)	1.86 (0.86, 4.02)	1.89 (0.86, 4.13)
Q4 (≥ 2.74)	855	25 (2.92%)	2.14 (1.09, 4.17)	2.39 (1.21, 4.71)	1.77 (0.80, 3.92)	1.82 (0.81, 4.07)

Model 1 was adjusted for age

Model 2 was adjusted for age, BMI, SBP, DBP

Model 3 was adjusted for age, BMI, SBP, DBP, diabetes mellitus, stroke, CHD, antihypertensive drugs, lipoprotein-lowering drugs, glucose-lowering drugs, current smoking, current drinking, education, physical activity

Model 4 was adjusted for age, BMI, SBP, DBP, diabetes mellitus, stroke, CHD, antihypertensive drugs, lipoprotein-lowering drugs, glucose-lowering drugs, current smoking, current drinking, education, physical activity, Hcy, FBG, TC, LDL, eGFR, serum aspartate aminotransferase, serum alanine aminotransferase, serum γ-glutamyltransferase